[1]
Veltkamp, M., Drent, M. and Baughman, R.P. 2016. Infliximab or biosimilars in sarcoidosis; to switch or not to switch?. Sarcoidosis, Vasculitis and Diffuse Lung Disease. 32, 4 (Jan. 2016), 280–283.